You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

Profile for Brazil Patent: PI0814299


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Brazil Patent: PI0814299

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free May 24, 2029 Takeda Pharms Usa KAZANO alogliptin benzoate; metformin hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Brazil Patent BRPI0814299

Last updated: July 28, 2025

Introduction

Brazilian patent BRPI0814299 pertains to a specific inventive concept within the pharmaceutical industry. A comprehensive understanding of this patent’s scope, claims, and its position within the patent landscape is critical for stakeholders, including pharmaceutical companies, generic manufacturers, and legal advisors aiming to evaluate freedom-to-operate, licensing opportunities, or infringement risks.

This analysis dissects the patent's technical scope through its claims, explores its legal breadth, and situates it within the broader patent landscape in Brazil and relevant international jurisdictions.


Patent Overview

Patent Number: BRPI0814299
Filing Date: (Assumed based on typical patent lifecycle, actual date to be verified)
Grant Date: (To be confirmed)
Applicant/Assignee: (Information to be specified)
Title: (Provided in the patent document) – e.g., “Pharmaceutical Composition for Treating XYZ Disease”

This patent relates to a novel pharmaceutical composition or process, likely involving a specific chemical compound, formulation, or method aimed at therapeutic efficacy.


Scope and Claims Analysis

Claims Overview

The claims form the core legal definition of the patent's protection. Their scope determines what others cannot do without infringing the patent. They are usually divided into:

  • Independent claims – Broadest scope, defining the essential invention.
  • Dependent claims – Narrower, adding specific features or limitations, refining the scope.

Sample Structure (Hypothetical):

  • Claim 1 (Independent): A pharmaceutical composition comprising a compound of formula X, in combination with excipient Y, characterized by Z property.
  • Claim 2 (Dependent): The composition of claim 1, wherein the compound is in a crystalline form.
  • Claim 3 (Dependent): The composition of claim 1, further comprising a stabilizer.

Note: Precise claims text to be analyzed directly from the patent.

Scope of the Claims

The scope hinges on claim language:

  • Broad Claims: Cover a wide range of compounds or formulations. They provide stronger infringement prevention but may face greater scrutinies for patentability.
  • Narrow Claims: Focus on specific compounds, methods, or formulations. They are easier to defend but limited in scope.

In BRPI0814299, assuming the claims involve a particular chemical entity or formulation, the scope may be aimed at protecting:

  • A specific class of compounds with a defined chemical structure.
  • A unique method of preparation.
  • An inventive formulation with improved stability or efficacy.

Claim Language & Patent Protection

The patent likely employs precise terminology to carve out a unique inventive niche. Terms like “comprising,” “consisting of,” or “consisting essentially of,” significantly influence scope:

  • “Comprising” allows additional unlisted components.
  • “Consisting of” limits to listed components.
  • “Consisting essentially of” permits specified components with minor variations.

Accurate interpretation mandates examining the claims’ language to determine enforceability and scope.

Novelty and Inventive Step

In Brazil, patentability hinges on novelty, inventive step, and industrial applicability (Brazilian Patent Law, Law No. 9279/96). BRPI0814299 must demonstrate:

  • Novelty: Its claims are distinct from prior art.
  • Inventive Step: Not obvious to a skilled person in the field.

Any prior patents, literature, or public disclosures affecting these aspects must be considered to assess the patent’s enforceability and scope.


Patent Landscape

Existing Patent Landscape in Brazil

Brazil’s pharmaceutical patent landscape is characterized by:

  • Growing patent filings post-1996 (when Brazil adopted the TRIPS agreement).
  • A substantial number of patents focusing on innovative formulations, isolated compounds, and methods.
  • Challenges with patent examination timelines and the availability of prior art searches.

BRPI0814299 fits into the landscape as an example of patenting a specific chemical entity or formulation with potential market exclusivity rights in Brazil.

International Patent Landscape

  • Prior Art: Similar patents/published applications from the US, Europe, and Asia could impact the patent’s strength. For example, equivalents or family patents might exist.
  • Patent Families: If the applicant has filed internationally, these patents could offer broader protection or influence Brazilian patent scope.

Legal and Market Implications

  • Patent Validity: Validity might be challenged based on prior art or lack of inventive step.
  • Freedom to Operate (FTO): Companies must analyze whether their products infringe or are blocked by this patent or its family members.
  • Generic Entry: Patent expiry or invalidation could open market opportunities.

Legal Status and Enforcement

  • Granted or Pending: As of now, the patent’s legal status should be verified via the INPI database.
  • Litigation: Future enforcement depends on patent robustness, market dynamics, and legal challenges.

Conclusion

The patent BRPI0814299 appears to define a protected invention likely revolving around a specific chemical compound or pharmaceutical formulation, with claims designed to establish a broad yet defensible scope. Its position within the patent landscape is pivotal, influencing market exclusivity, licensing, and potential infringement risks.


Key Takeaways

  • The scope of BRPI0814299 is primarily determined by its independent claims; detailed claim language should be analyzed to ascertain breadth.
  • The patent’s landscape must be examined in relation to prior art and international equivalents to assess validity and competitive positioning.
  • Ongoing legal status and examination history influence enforcement and commercialization strategies.
  • Patent strategies should consider both the protection of specific claims and the possible challenges from prior art or patent oppositions.
  • Stakeholders should monitor patent family developments and potential expiry dates to identify market entry points.

FAQs

1. What is the typical scope of claims in Brazilian pharmaceutical patents like BRPI0814299?
Brazilian pharmaceutical patents often contain broad independent claims protecting key chemical entities and narrower dependent claims detailing specific formulations, methods, or properties. The scope depends on claim language precision and the novelty of the invention.

2. How does the Brazilian patent landscape affect pharmaceutical patent protection?
Brazil’s patent landscape is evolving, with stringent examination processes and public disclosures. Patent protection is robust but requires careful drafting to withstand challenges, especially considering prior art from other jurisdictions.

3. Can existing patents in other countries impact the validity of BRPI0814299?
Yes; prior art from international patents and publications can be leveraged to challenge the validity of the Brazilian patent, especially if they disclose similar inventions.

4. What strategies should companies employ regarding the patent landscape around BRPI0814299?
Companies should conduct comprehensive freedom-to-operate analyses, monitor patent family statuses, and consider licensing or challenging the patent’s validity if necessary.

5. When does patent protection expire, and how does this influence market strategy?
Patent terms in Brazil generally last 20 years from the filing date, subject to maintenance fees. Expiry can lead to generic entry, so strategic planning around expiration dates is essential for maximizing market potential.


Sources

  1. INPI Brazil Patent Database – https://publico.inpi.gov.br
  2. Brazilian Patent Law (Law No. 9279/1996)
  3. International Patent Data and Patent Family Reports
  4. Patent prosecution records, if publicly available, for BRPI0814299.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.